Cambridge Investment Research Advisors, Inc.
Position in VTRS — Viatris Inc
CIK 1419186
FAIRFIELD, IA
Position in VTRS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,238,317
+$701,731 QoQ
Shares Held
140,952
+23.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#244
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $28,058,357 across 19 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
64,199 | $7,122,237 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
127,996 | $3,247,258 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,625 | $3,047,793 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,650 | $2,969,582 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
79,024 | $2,739,762 | |
| 6 | ZTS |
Zoetis Inc.
|
34,463 | $2,476,511 | |
| 7 | VTRS |
Viatris Inc
This page
|
140,952 | $2,238,317 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
6,718 | $1,132,251 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,238,317 | 140,952 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,536,586 | 113,737 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,703,110 | 136,796 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,478,743 | 149,368 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,341,616 | 150,237 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,245,904 | 143,043 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,710,505 | 137,390 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,610,632 | 138,728 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,692,678 | 159,236 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,940,417 | 162,514 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,814,999 | 167,590 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,770,274 | 179,541 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,739,673 | 174,316 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,426,039 | 148,237 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,617,778 | 145,353 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,625,888 | 190,832 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,748,134 | 166,966 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,764,540 | 162,182 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,891,263 | 139,783 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,939,628 | 143,146 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,900,584 | 202,980 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,923,208 | 209,249 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $3,870,109 | 206,516 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||